icon star paper   Hepatitis B Articles (HBV)  
Back grey_arrow_rt.gif
 
 
Antiviral Therapy for Chronic Hepatitis B Reduces the Incidence of Hepatocellular Carcinoma Regardless of Cirrhosis Status: Analysis with Adjustment for REACH-B Risk Score
 
 
  Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
 
Hwai-I Yang, PhD
 
Derek Lin1; Hwai-I Yang2,3; Nghia H. Nguyen4,5; Joseph Hoang4; Yoona Kim4; Vinh Vu4; An Le4; Kevin Chaung4,6; Vincent Nguyen4,6; Huy Trinh7; Jiayi Li8; Jian Zhang9; Ann Hsing10,11,12; Chien-Jen Chen2,13; Mindie H. Nguyen
 
1 Department of Internal Medicine, Stanford University Medical Center, USA
2 Genomics Research Center, Academia Sinica, Taiwan
3 Institute of Clinical Medicine, National Yang-Ming University, Taiwan
4 Division of Gastroenterology and Hepatology, Stanford University Medical Center, USA
5 Department of Internal Medicine, University of California San Diego, USA
6 Pacific Health Foundation, USA
7 San Jose Gastroenterology, USA
8 Palo Alto Medical Foundation, Mountain View Division, USA
9 Chinese Hospital, San Francisco, USA
10 Cancer Prevention Institute of California, USA
11 Stanford Cancer Institute, Stanford School of Medicine, USA
12 Health Research and Policy Department, Stanford School of Medicine, USA
13 Graduate Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taiwan

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif

 
 
 
 
  icon paper stack View Older Articles   Back to Top   www.natap.org